Skip to content

Journey Medical Corporation DERM Amortization of capitalized software and acquired intangible assets

Amortization of capitalized software and acquired intangible assets at other companies

PTH
Pelthos Therapeutics Inc.PTHS
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
HRO
HarrowHROW
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total debt$25.5M+1.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by Journey Medical Corporation in its filing.

Tagged under the XBRL concept us-gaap:AmortizationOfIntangibleAssets.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's amortization of capitalized software and acquired intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's amortization of capitalized software and acquired intangible assets?
Journey Medical Corporation (DERM) reported amortization of capitalized software and acquired intangible assets of $1.13M in Q1 2026.
How has Journey Medical Corporation's amortization of capitalized software and acquired intangible assets changed year-over-year?
Journey Medical Corporation's amortization of capitalized software and acquired intangible assets increased by 5.7% year-over-year, from $1.07M to $1.13M.
What is the long-term trend for Journey Medical Corporation's amortization of capitalized software and acquired intangible assets?
Over 4 years (2021 to 2025), Journey Medical Corporation's amortization of capitalized software and acquired intangible assets has grown at a 14.5% compound annual growth rate (CAGR), from $2.48M to $4.26M.